{"id":"W2520697216","doi":"","title":"Randomized phase 3 trial of regorafenib in patients (pts) with metastatic and/or unresectable gastrointestinal stromal tumor (GIST) progressing despite prior treatment with at least imatinib (IM) and sunitinib (SU) - GRID trial","year":2012,"lang":"en","type":"article","venue":"Data Archiving and Networked Services (DANS)","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Regorafenib; Sunitinib; GiST; Medicine; Imatinib; Internal medicine; Oncology; Sunitinib malate; Stromal tumor; Randomized controlled trial; Stromal cell; Colorectal cancer; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001176811,0.001534819,0.002348813,0.0002684109,0.0003852526,0.00105334,0.0006723127,0.0009615357,0.009520786],"category_scores_gemma":[0.001261447,0.0004351833,0.001951828,0.0003090833,0.001006266,0.0009880004,0.0004234491,0.003249736,0.001536838],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00104214,"about_ca_system_score_gemma":0.001221453,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001931533,"about_ca_topic_score_gemma":0.005693976,"domain_scores_codex":[0.9996314,0.0001947599,0.0000130733,0.00006984223,0.00001983742,0.00007109461],"domain_scores_gemma":[0.9994482,0.0001153379,0.0001126578,0.00006237689,0.00003018712,0.0002311424],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9570768,0.003723208,0.001464691,0.0004387539,0.001403985,0.00009008962,0.00007246523,0.001527145,0.002757972,0.0003238638,0.005438353,0.02568264],"study_design_scores_gemma":[0.9600912,0.03355695,0.002553257,0.00002157943,0.0003708026,0.0001024496,0.0000362066,0.0005977948,0.0003063216,0.0004297726,0.001918926,0.00001479378],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9783379,0.003905045,0.0009685942,0.002591156,0.0008489386,0.002465641,0.004492684,0.000372585,0.006017325],"genre_scores_gemma":[0.9798462,0.00210086,0.001851592,0.002344273,0.0003026852,0.002727324,0.004815826,0.00007029562,0.00594101],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009520786,"threshold_uncertainty_score":0.03185022,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04755688638292465,"score_gpt":0.3274462579719044,"score_spread":0.2798893715889797,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}